Prosecution Insights
Last updated: October 24, 2026
Application No. 18/456,826

HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE HETEROCYCLIC COMPOUND

Non-Final OA §102§103
Filed
Aug 28, 2023
Priority
Aug 29, 2022 — RE 10-2022-0108725
Examiner
BOHATY, ANDREW K
Art Unit
1759
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Samsung Electronics Co., Ltd.
OA Round
1 (Non-Final)
66%
Grant Probability
Favorable
1-2
OA Rounds
4m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allowance Rate
617 granted / 939 resolved
+0.7% vs TC avg
Strong +23% interview lift
Without
With
+23.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
27 currently pending
Career history
973
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
56.2%
+16.2% vs TC avg
§102
12.6%
-27.4% vs TC avg
§112
17.3%
-22.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 939 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1, 2, 4-11, 13-16, and 19 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kim et al. (WO 2021/020928), where Kim et al. (US 2023/0077439) (hereafter “Kim”) is used as the English equivalent. Regarding claims 1, 2, 4-11, 13-16, and 19, Kim teaches an electroluminescent device comprising an anode, a hole transporting layer, a light emitting layer, an electron transporting layer, and a cathode (paragraphs [0818]-[0823]) (claims 13-15). Kim teaches the light emitting layer comprises a host and a blue emitting dopant and that the amount of the host is greater than that dopant (paragraphs [0818]-[0823]) (claims 14-16 and 19). Kim teaches that the dopant can have the following structure, PNG media_image1.png 227 266 media_image1.png Greyscale , PNG media_image2.png 238 263 media_image2.png Greyscale , PNG media_image3.png 216 234 media_image3.png Greyscale , or PNG media_image4.png 201 259 media_image4.png Greyscale are a few examples (paragraphs [0365] and [0818]-[0823]) (claims 1, 2, and 4-11). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-19 is/are rejected under 35 U.S.C. 103 as being unpatentable over Shin et al. (US 2021/0104682) (hereafter “Shin”) in view of Kim et al. (WO 2021/020928), where Kim et al. (US 2023/0077439) (hereafter “Kim”) is used as the English equivalent. Regarding claims 1-19, Shin teaches an electroluminescent device comprising an anode, a hole transporting layer, a light emitting layer, an electron transporting layer, and a cathode (paragraphs [0335]-[0346]) (claims 13-15). Shin teaches that the light emitting layer comprises a host material, a phosphorescent dopant (sensitizer), and a fluorescent dopant that emits blue light and the amount of the host material is greater than both dopant materials (between 400-490nm) (paragraphs [0030] and [0337]) (claims 14-19). Shin teaches that the fluorescent dopant can have the following structure, PNG media_image5.png 159 177 media_image5.png Greyscale , PNG media_image6.png 215 184 media_image6.png Greyscale , PNG media_image7.png 205 212 media_image7.png Greyscale , or PNG media_image8.png 245 181 media_image8.png Greyscale are a few examples (paragraphs [0101] and [0335]-[0346]). Shin does not teach where the fluorescent dopant comprises a group that meets formula 2. Kim teaches an electroluminescent device comprising similar boron fluorescent dopants (paragraphs [0002] and [0010]). Kim teaches that adding a group with a cycloalkene ring to the compound can improve the stability of the compounds due to the lowering the sublimation temperature (paragraph [0050]). This can lead to an improvement in the lifetime and efficiency of the device with the compound (paragraph [0050]). Kim teaches that the group with the cycloalkyl group can be attached to the N atom in the boron heterocyclic compound, such as in PNG media_image2.png 238 263 media_image2.png Greyscale (paragraph [0101]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the fluorescent dopants of Shin so the phenyl groups are substituted with PNG media_image9.png 77 86 media_image9.png Greyscale groups as taught by Kim. The motivation would have been to improve the stability of the compound and improve the efficiency and lifetime of the device. This would lead to compounds that meet applicant’s claimed compounds 6 and 8 as examples. Claim(s) 17 and 18 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kim et al. (WO 2021/020928), where Kim et al. (US 2023/0077439) (hereafter “Kim”) is used as the English equivalent, as applied to claims 1, 2, 4-11, 13-16, and 19 above, and further in view of Lin et al. (US 2019/0341557). Regarding claims 17 and 18, Kim does not teach where the light emitting layer further comprises a sensitizer. Lin teaches adding a sensitizer to a layer can help transfer energy to the emitting dopant in electroluminescent devices (paragraph [0124]). It would have been obvious to one of ordinary skill int the art before the effective filing date of the claimed invention to modify the device of Kim so the emitting layer comprises a sensitizer as taught by Lin. The motivation would have been to increase the transfer of energy to the emitting dopant. Claim(s) 20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kim et al. (WO 2021/020928), where Kim et al. (US 2023/0077439) (hereafter “Kim”) is used as the English equivalent, as applied to claims 1, 2, 4-11, 13-16, and 19 above, and further in view of Lee et al. (US 2018/0179238) (hereafter “Lee”). Regarding claim 20, Kim does not teach where emitting dopant is used in a diagnostic composition. Lee teaches electroluminescent device comprising a light emitting layer (paragraphs [0332]-[0334]). Lee teaches that the light emitting dopant material can as be used in diagnostic composition (paragraphs [0007], [0046], [0272], and [0273]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to try to use the emitting dopant of Kim in a diagnostic composition as taught by Lee. Both Kim and Lee teach emitting dopants for use in the light emitting layer of an electroluminescent device, but only Lee teaches that the materials can also be used in diagnostic composition. Given the similarity between the Lee and Kim it would have been obvious to try to use the emitting material of Kim in a diagnostic material. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Kim et al. (US 2021/0104681) teaches a light emitting layer comprising two hosts, a sensitizer, and a boron heterocyclic compound as the emitting material. Sim et al. (US 2023/0146532) teaches compounds that meets the applicant’s claimed invention. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANDREW K BOHATY whose telephone number is (571)270-1148. The examiner can normally be reached Monday-Friday 7am-4pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Curtis Mayes can be reached at (571)272-1234. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANDREW K BOHATY/Primary Examiner, Art Unit 1759
Read full office action

Prosecution Timeline

Aug 28, 2023
Application Filed
Oct 14, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12760048
COMPOSITION CONTAINING IRIDIUM COMPLEX, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGE PICKUP DEVICE, ELECTRONIC DEVICE, ILLUMINATION APPARATUS, AND MOVING OBJECT
3y 5m to grant Granted Oct 13, 2026
Patent 12757608
DISPLAY DEVICE
4y 5m to grant Granted Oct 06, 2026
Patent 12757633
ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS
4y 6m to grant Granted Oct 06, 2026
Patent 12757626
ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
3y 8m to grant Granted Oct 06, 2026
Patent 12742115
ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS
4y 0m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
66%
Grant Probability
89%
With Interview (+23.1%)
3y 6m (~4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 939 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month